繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Assertio Holdings任命Schwichtenberg为CTO,Pietrya为CCO

2024-12-12 21:37

  • Assertio Holdings (NASDAQ:ASRT) has announced the creation of a new Transformation Office and the appointment of Paul Schwichtenberg as Chief Transformation Officer.
  • Mr. Schwichtenberg currently serves as the company’s Chief Commercial Officer and was previously CFO.
  • In addition, Mary Pietryga will be appointed as Chief Commercial Officer, effective Dec. 16, 2024, with responsibility for sales, marketing and commercial access, taking over from Schwichtenberg.
  • Ms. Pietryga joins Assertio from Teva Pharmaceuticals, where she was Vice President and Head of the Global Biosimilar Portfolio.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。